S'abonner

Effects of high-intensity interval training on cardiorespiratory function in coronary artery disease: An overview of systematic reviews - 01/08/24

Doi : 10.1016/j.rehab.2024.101878 
Yingtian Yang, MD a, b, 1 , Qianyu Lv, MD a, 1, Xirui Zhang, MD c, Qian Wu, MD a, Lanlan Li, MD a, Xuejiao Ye, MD a, Shihan Wang, MD a,
a Department of Cardiovascular Internal Medicine, Guang 'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, P. R. China 
b Faculty of Clinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, P. R. China 
c Department of Geriatrics, Baogang Hospital, Inner Mongolia Medical College Third Affiliated Hospital, Baotou 014010, P. R. China 

Correspondence
Sous presse. Manuscrit accepté. Disponible en ligne depuis le Thursday 01 August 2024

Abstract

Background

Exercise-based cardiac rehabilitation has been identified as a crucial component in mitigating all-cause mortality among individuals diagnosed with coronary artery disease (CAD). Nevertheless, the optimal exercise prescription remains elusive.

Objective

The purpose of this overview is to conduct a systematic evaluation and synthesis of the evidence derived from systematic reviews/meta-analyses (SRs/MAs) regarding the effects on cardiorespiratory fitness and safety of high-intensity interval training (HIIT) compared to moderate-intensity continuous training (MICT) for CAD.

Methods

SRs/MAs were searched across 5 databases from inception until March 22, 2023. We assessed methodological quality using the Assessing the Methodological Quality of Systematic Reviews 2 (AMSTAR-2). The risk of bias, reporting, and evidence were evaluated using the Risk of Bias in Systematic Reviews (ROBIS) tool, the Preferred Reporting Item for Systematic Review and Meta-analysis (PRISMA) 2020, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system, respectively.

Results

In total, 9 SRs/MAs were included. Based on the AMSTAR-2 criteria, 4 and 5 studies were considered low- and critically-low quality, respectively. None of the studies reported all 27 items outlined in the PRISMA 2020 checklist. Regarding the ROBIS evaluation, 4 reviews were rated as low risk, 4 as high risk, and 1 as unclear risk. The GRADE evaluation indicated 3 high-level evidence, 20 moderate-level evidence, 28 low-level evidence, and 34 very low-level evidence studies based on 85 indicators. Moderate- to high-quality evidence supported that HIIT is superior to MICT in improving VO2peak for CAD.

Conclusion

The efficacy and time cost of developing cardiorespiratory fitness support HIIT as an adjunct or alternative to MICT. The evidence does not permit a definitive decision regarding the adverse effects of HIIT compared to MICT. Because of the insufficient quality of the evidence, future studies should focus more on the quality of randomized controlled trials and evidence for SRs/MAs to provide scientific and robust evidence for conclusions.

Trial Registration

The review was registered at PROSPERO: CRD42023420015

Le texte complet de cet article est disponible en PDF.

Keywords : High-intensity interval training, Moderate-intensity continuous training, Coronary artery disease, Cardiac rehabilitation, Overview

Abbreviations : AMSTAR-2, CAD, CR, GRADE, HF, HIIT, HRpeak, JBI-MAStARI, MD, MICT, PEDro-Scale, PRISMA, PROSPERO, RCT, RoB, ROBIS, SMD, SRs/MAs, VE/VCO2, VO2peak, WMD


Plan


 Declarations of interest: None


© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.